BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6804562)

  • 41. Abnormal anterior chamber associated immune deviation (ACAID) in 129-strain mice.
    Herndon J; Gibler TS; Ferguson TA; Van Gelder RN
    Ocul Immunol Inflamm; 2006 Feb; 14(1):7-12. PubMed ID: 16507485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promotion of syngeneic intraocular tumor growth in mice by anterior chamber-associated immune deviation.
    Niederkorn JY; Streilein JW; Kripke ML
    J Natl Cancer Inst; 1983 Jul; 71(1):193-9. PubMed ID: 6575203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production.
    Kosiewicz MM; Alard P; Streilein JW
    J Immunol; 1998 Nov; 161(10):5382-90. PubMed ID: 9820512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors.
    Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1989 Feb; 30(2):323-9. PubMed ID: 2492486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphoma allografts abrogate immune privilege within the anterior chamber of the eye.
    Niederkorn JY; Streilein JW
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1235-43. PubMed ID: 3089965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
    Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties.
    Wilbanks GA; Streilein JW
    Reg Immunol; 1992; 4(3):130-7. PubMed ID: 1303096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anterior chamber-associated immune deviation induced by soluble antigens.
    Mizuno K; Clark AF; Streilein JW
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1112-9. PubMed ID: 2732026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The immune response and the eye. II. The nature of T suppressor cell induction in anterior chamber-associated immune deviation (ACAID).
    Ferguson TA; Waldrep JC; Kaplan HJ
    J Immunol; 1987 Jul; 139(2):352-7. PubMed ID: 2955039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of immune deviation elicited by antigens injected into the subretinal space.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
    Geiger K; Sarvetnick N
    J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of anterior chamber-associated immune deviation (ACAID) in aged retinal degeneration (rd) mice.
    Welge-Lüssen U; Wilsch C; Neuhardt T; Wayne Streilein J; Lütjen-Drecoll E
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3209-14. PubMed ID: 10586944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anterior chamber-associated immune deviation induced by TNP-splenocytes (TNP-ACAID). II. Suppressor T-cell networks.
    Waldrep JC; Kaplan HJ
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1339-45. PubMed ID: 6225745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclophosphamide-sensitive contrasuppression in TNP-anterior chamber associated immune deviation (TNP-ACAID).
    Waldrep JC; Kaplan HJ
    J Immunol; 1983 Dec; 131(6):2746-50. PubMed ID: 6196397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye.
    Niederkorn JY; Streilein JW
    Transplantation; 1982 Jun; 33(6):573-7. PubMed ID: 6808721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gammadelta T cells in anterior chamber-induced tolerance in CD8(+) CTL responses.
    Xu Y; Kapp JA
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3473-9. PubMed ID: 12407158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.
    Zhang Y; Zhang M; Zhao S; Li X; Jia Z; Zhang L; Han ZC; Zhang X
    Int Immunopharmacol; 2013 Jan; 15(1):114-20. PubMed ID: 23178576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice.
    Wang Y; Goldschneider I; Foss D; Wu DY; O'Rourke J; Cone RE
    J Immunol; 1997 Mar; 158(5):2150-5. PubMed ID: 9036960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reconsidering the immunologic privilege and lymphatic drainage of the anterior chamber of the eye.
    Niederkorn JY; Lynch MG
    Transplant Proc; 1989 Feb; 21(1 Pt 1):259-60. PubMed ID: 2495604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.